VIDAS offers a flexible and easy way to rapidly detect IgM & IgG antibodies of individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

  • Detects the presence of antibodies by using the S1/receptor-binding domain (RBD) of the SARS- CoV-2 S protein 
  • Reliable results in 27 minutes 
  • Two tests with the same protocol to differentiate lgM & lgG results 
  • Provides index value and no equivocal zone
  • Ideal for either individual or batch testing 
  • Ready-to-use reagents with calibration materials included in kits 
  • Available on all VIDAS platforms (MINI VIDAS, VIDAS, VIDAS 3) 
  • Minimal maintenance and easy to use

VIDAS® SARS-COV-2 IgM & IgG is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .

Buy VIDAS® SARS-COV-2 IgM & IgG for Detecting SARS-CoV-2 for Your WorkPlace

If your company or organisation is interested in rapid testing solutions, contact us today for help procuring VIDAS® SARS-COV-2 IgM & IgG for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA)

If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for VIDAS® SARS-COV-2 IgM & IgG for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.

Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Kindly use the webchat to contact us. This is the most efficient way for us to track and respond to your query. Thank you for your understanding.

Proudly trusted by hundreds of organisations across the Globe

Stay up to date with Rapid Test & Trace Australia

Scroll to Top